TFA Therapeutics ratios data for the quarter ended Dec 2025. These financial ratios cover 7 quarters of results from Dec 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2020 | Dec2021 | Dec2022 | Sep2023 | Dec2023 | Dec2024 | Dec2025 |
|---|---|---|---|---|---|---|---|
| Profitability | |||||||
| Gross Margin | 90.22% | ||||||
| EBT Margin | 26.44% | ||||||
| EBIT Margin | 38.18% | ||||||
| EBITDA Margin | 93.34% | ||||||
| Operating Margin | 38.18% | ||||||
| Net Margin | 285.63% | ||||||
| FCF Margin | -778.06% | ||||||
| Efficiency | |||||||
| Inventory AverageInventory Avg. | 0.58M | 0.24M | 0.00M | ||||
| Assets AverageAssets Avg. | 3.04M | 2.68M | 1.95M | 2.57M | 3.99M | 4.64M | |
| Equity AverageEquity Avg. | -0.14M | -0.61M | -0.57M | -0.17M | -0.26M | -0.46M | |
| Invested CapitalInvested Cap. | 1.49M | 1.25M | -0.47M | 0.23M | 2.88M | 3.97M | 3.94M |
| Leverage & Solvency | |||||||
| Debt Ratio | 0.53 | 0.47 | 0.23 | 0.23 | 0.91 | 0.94 | 0.96 |
| Valuation | |||||||
| Enterprise Value | 916.70M | 1,020.08M | |||||
| Market Capitalization | 916.74M | 1,020.08M | |||||
| Return Ratios | |||||||
| Return on Sales [ROS]ROS | 38.18% |
Pull TFA Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=RAJAF&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "RAJAF", "statement": "Ratios", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=RAJAF&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();